Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
22 May 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979
Reference Type:
other: TSCATS
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
concentration was measured, but not humidity, temperature and particle size.
Principles of method if other than guideline:
BASF-Test
GLP compliance:
no
Test type:
fixed concentration procedure
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)
EC Number:
229-962-1
EC Name:
2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)
Cas Number:
6864-37-5
Molecular formula:
C15H30N2
IUPAC Name:
4-[(4-amino-3-methylcyclohexyl)methyl]-2-methylcyclohexan-1-amine

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: WIGA, Sulzfeld and MUS RATTUS, Brunnthal, Germany
- Weight at study initiation: 185±15 g (mean)
- Diet: Herilan MRH (H. EGGERSMANN KG) ad libitum
- Water: tap water ad libitum

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose/head only
Remarks:
dynamic method
Vehicle:
other: unchanged (no vehicle)
Analytical verification of test atmosphere concentrations:
yes
Remarks:
gas chromatography
Duration of exposure:
4 h
Concentrations:
0.053, 0.31, 0.41, 0.62 mg/L (analytical concentration) [0.31, 1.41, 1.83, 2.13 mg/L (nominal concentration)]
No. of animals per sex per dose:
10
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Frequency of weighing: days 0, 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
Statistical evaluation included a probit analysis accordinmg to D.J. Finney.

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LC50
Effect level:
0.42 mg/L air (analytical)
Exp. duration:
4 h
Sex:
male
Dose descriptor:
LC50
Effect level:
0.44 mg/L air (analytical)
Exp. duration:
4 h
Sex:
female
Dose descriptor:
LC50
Effect level:
0.4 mg/L air (analytical)
Exp. duration:
4 h
Mortality:
0.62 mg/L air: 9/10 (males); 10/10 (females)
0.41 mg/L air: 3/10 (males); 5/10 (females)
0.31 mg/L air: 2/10 (males); 1/10 (females)
0.053 mg/L air: 0/10 (males); 0/10 (females)
Clinical signs:
other: Animals showed apathy, staggering, squatting and abdominal position, ruffled fur and in general clinical symptoms that were indicative of a marked irritant effect on the airways and eyes such as eyelid closure, watery eye and nose discharge and corneal op
Body weight:
Some retardation in body weight gain was observed in the treated animals during the post observation. However, there was no clear dose-response and body weights were not statistically significantly different from control at the end of the postobservation period.
Gross pathology:
Animals that died:
heart: acute dilatation of the right ventricle, acute congestive hyperemia;
lungs: focal hyperemia, additional moderate edema;

Sacrificed animal: no pathologic findings noted.

Any other information on results incl. tables

Test concentrations and mortality:

Dose (mg/L)   male  female
 0.62  9/10  10/10
 0.41  3/10  5/10
0.31  2/10  1/10
 0.053  0/10  0/10

Body weight:

Mean body weight (in g)   male        female     
   0 days  7 days  14 days  0 days  7 days  14 days
0.62 mg/L 189 (10) 196 (1) 233 (1) 178 (10) - -
0.41 mg/L 180 (10) 166 (7) 233 (7) 177 (10) 188 (5) 209 (5)
0.31 mg/L 181 (10) 189 (8) 234 (8) 184 (10) 185 (9) 198 (9)
0.053 mg/L 190 (10) 202 (10) 240 (10) 184 (10) 189 (10) 203 (10)
control 182 (10) 220 (10) 253 (10) 175 (10) 182 (10) 194 (10)

(): number of animals;

"-": all animals dead.

Applicant's summary and conclusion

Interpretation of results:
Category 2 based on GHS criteria